Results 121 to 130 of about 1,178,962 (294)

Cosmetics use-related adverse events

Chinese Medical Journal, 2019
Su-Lian Yang, Yue Zheng, Yun-Qing Zhang, Cong-Xiu Ye, Jin-Ling Yi, Yu-Fang Liu, Wei Lai, Li-Shao Guo   +7 more
doaj   +1 more source

Adverse events following immunization (AEFI) in patients with Primary Immunodeficiencies.

, 2015
Sarmiento Delgado Juan, Trujillo Vargas Claudia, Villada Fabio, Orrego Arango Julio, Franco Jose   +4 more
openalex   +1 more source

Prevalence and correlates of voluntary medical male circumcision adverse events among adult males in the Copperbelt Province of Zambia: A cross-sectional study

, 2021
Imukusi Mutanekelwa, Seter Siziya, Victor Daka, Kabelenga Elijah, Ruth Lindizyani Mfune, Misheck Chileshe, David Mulenga, Herbert Tato Nyirenda, Christopher Nyirenda, Steward Mudenda, Bright Mukanga, Kasonde Bowa   +11 more
openalex   +2 more sources

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin, Liu Dong, Ying Wang, Dingxian He, Chong Yan, Jianying Xi, Haoqin Jiang, Yu Shi, Ming Guan, Chongbo Zhao, Jie Song, Sushan Luo   +11 more
wiley   +1 more source

Commentary: Musculoskeletal adverse events in dogs receiving bedinvetmab (Librela). [PDF]

Front Vet Sci
Lloyd A.
europepmc   +2 more sources

Hospital Work Conditions and the Mediation Role of Burnout: Residents and Practicing Physicians Reporting Adverse Events

, 2023
Mu’taman Jarrar, Mohammad Al‐Bsheish, Waleed Albaker, Ibtihal Alsaad, Eiman Abdulhameed Alkhalifa, Sara Alnufaili, Nour Almajed, Reem Z. Alhawaj, Mohammed Al-Hariri, Ahmed Alsunni, Badr K. Aldhmadi, Arwa Alumran   +11 more
openalex   +2 more sources

Cutaneous Phosphorylated Alpha‐Synuclein in Lewy Body Dementia

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine the test performance of cutaneous phosphorylated alpha‐synuclein (P‐SYN) in dementia with Lewy bodies (DLB), individuals with reduced Montreal Cognitive Assessment (MoCA) and healthy controls. Methods This is the first subgroup analysis of the Synuclein‐One study, a prospective, blinded study evaluating P‐SYN detection ...
Christopher H. Gibbons, Todd Levine, Charles H. Adler, Bailey Bellaire, Ningshan Wang, Pinky Agarwal, Georgina M. Aldridge, Alexandru Barboi, Daniel Claassen, Virgilio G. H. Evidente, Douglas Galasko, Alejandra Gonzalez‐Duarte, Ramon Gil, Mark Gudesblatt, Stuart H. Isaacson, Horacio Kaufmann, Pravin Khemani, Rajeev Kumar, Guillaume Lamotte, Andy J. Liu, Nikolaus R. McFarland, Mitchell G. Miglis, Adam Reynolds, Gregory A. Sahagian, Marie‐Helene Saint‐Hilaire, Julie B. Schwartzbard, Wolfgang Singer, Michael J. Soileau, Steven Vernino, Patricio Millar Vernetti, Oleg Yerstein, Roy Freeman   +31 more
wiley   +1 more source

Measuring infant response to early adverse events in the mouse

, 2009
Moles Anna
openalex   +1 more source

Anti VEGF-TKI Treatment and New Renal Adverse Events Not Reported in Phase III Trials [PDF]

, 2018
Luisa Paschke, Thomas Lincke, Katja S. Mühlberg, Wolfram J. Jabs, Tom H. Lindner, Ralf Paschke   +5 more
openalex   +1 more source

Adverse events following Sinopharm (Vero Cell), the inactivated COVID-19

, 2021
Sushant Aryal, Ranjan Prasad Devbhandari, Shrijana Shrestha, Ashis Shrestha, Piyush Rajbhandari, Tripti Shakya, Shreyashi Tuladhar, Sanjay Maharjan, Ritu Bashyal, Ranjan Suwal, Deepshikha Mishra, Rakesh Kumar Jha   +11 more
openalex   +2 more sources